167 related articles for article (PubMed ID: 17553209)
1. Anaphylaxis to leuprolide acetate depot injection during treatment for prostate cancer.
Grant JP; Levinson AW
Clin Genitourin Cancer; 2007 Mar; 5(4):284-6. PubMed ID: 17553209
[TBL] [Abstract][Full Text] [Related]
2. Life-threatening anaphylaxis to leuprorelin acetate depot: case report and review of the literature.
Fujisaki A; Kondo Y; Goto K; Morita T
Int J Urol; 2012 Jan; 19(1):81-4. PubMed ID: 22050405
[TBL] [Abstract][Full Text] [Related]
3. Injection-site granulomas due to the administration of leuprorelin acetate for the treatment of prostatic cancer.
Shiota M; Tokuda N; Kanou T; Yamasaki H
Fukuoka Igaku Zasshi; 2007 Jul; 98(7):301-4. PubMed ID: 17710895
[TBL] [Abstract][Full Text] [Related]
4. Leuprolide acetate given by a subcutaneous extended-release injection: less of a pain?
Cox MC; Scripture CD; Figg WD
Expert Rev Anticancer Ther; 2005 Aug; 5(4):605-11. PubMed ID: 16111462
[TBL] [Abstract][Full Text] [Related]
5. Granulomas induced by subcutaneous injection of leuprorelin acetate.
Sakamoto R; Higashi Y; Mera K; Kanekura T; Kanzaki T
J Dermatol; 2006 Jan; 33(1):43-5. PubMed ID: 16469084
[TBL] [Abstract][Full Text] [Related]
6. Leuprolide acetate-induced generalized papular eruption.
Burris K; Ding CY; Lim GF
J Drugs Dermatol; 2014 Jun; 13(6):755-7. PubMed ID: 24918569
[TBL] [Abstract][Full Text] [Related]
7. Unusual side effect from a luteinizing hormone-releasing hormone agonist, leuprorelin, in the treatment of prostate cancer: a case report.
Chang JI; Bucci J
J Med Case Rep; 2016 Nov; 10(1):323. PubMed ID: 27836000
[TBL] [Abstract][Full Text] [Related]
8. What should I know about Lupron Depot for treating prostate cancer?
Johns Hopkins Med Lett Health After 50; 2012 Jan; 23(11):7. PubMed ID: 22396997
[No Abstract] [Full Text] [Related]
9. Leuprolide acetate-induced dermatitis herpetiformis.
Grimwood RE; Guevara A
Cutis; 2005 Jan; 75(1):49-52. PubMed ID: 15732435
[TBL] [Abstract][Full Text] [Related]
10. [Granulomas induced by injections of leuprorelin acetate (Enantone®)].
Bruneu-Avierinos Y; Monestier S; Tasei AM; Gaudy-Marqueste C; Grob JJ; Richard MA
Ann Dermatol Venereol; 2011 Jan; 138(1):35-7. PubMed ID: 21276459
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of androgen deprivation therapy after switching from monthly leuprolide to monthly degarelix in patients with prostate cancer.
de la Rosette J; Davis R; Frankel D; Kold Olesen T
Int J Clin Pract; 2011 May; 65(5):559-66. PubMed ID: 21342376
[TBL] [Abstract][Full Text] [Related]
12. Leuprorelin acetate in prostate cancer: a European update.
Persad R
Int J Clin Pract; 2002 Jun; 56(5):389-96. PubMed ID: 12137449
[TBL] [Abstract][Full Text] [Related]
13. [Surgical management of inflammatory granuloma which developed following subcutaneous injection of leuprorelin acetate: a case report].
Oida T; Shichiri Y; Takao N; Kanno T; Kanamaru H
Hinyokika Kiyo; 2005 Jul; 51(7):487-9. PubMed ID: 16119817
[TBL] [Abstract][Full Text] [Related]
14. Randomised crossover trial to assess the tolerability of LHRH analogue administration.
Williams G; Lindsay S; Bowsher WG
Prostate Cancer Prostatic Dis; 2003; 6(2):187-9. PubMed ID: 12806381
[TBL] [Abstract][Full Text] [Related]
15. Follicular mucinosis and mycosis-fungoides-like drug eruption due to leuprolide acetate: a case report and review.
Shalin SC; Brantley J; Diwan AH
J Cutan Pathol; 2012 Nov; 39(11):1022-5. PubMed ID: 22882386
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of adjuvant intermittent endocrine therapy following neoadjuvant endocrine therapy and external beam radiation therapy in men with locally advanced prostate cancer.
Yamanaka H; Ito K; Naito S; Tsukamoto T; Usami M; Fujimoto H; Matsuoka N; Fukui I; Harada M; Ohashi Y; Kotake T; Kakizoe T
Prostate; 2005 Apr; 63(1):56-64. PubMed ID: 15468166
[TBL] [Abstract][Full Text] [Related]
17. Pure red cell aplasia in a prostate cancer patient treated with leuprolide acetate and chlormadinone acetate.
Kobayashi M; Nukui A; Morita T
Int J Urol; 2005 Nov; 12(11):1010-1. PubMed ID: 16351663
[TBL] [Abstract][Full Text] [Related]
18. [Skin reaction induced by subcutaneous injection of LH-RH analogue].
Segawa N; Nishida T; Hamada S; Azuma H; Katsuoka Y; Nozaki K; Tsuji M
Hinyokika Kiyo; 2007 Oct; 53(10):695-8. PubMed ID: 18018584
[TBL] [Abstract][Full Text] [Related]
19. Leuprorelin acetate granulomas: case reports and review of the literature.
Yasukawa K; Sawamura D; Sugawara H; Kato N
Br J Dermatol; 2005 May; 152(5):1045-7. PubMed ID: 15888168
[TBL] [Abstract][Full Text] [Related]
20. Extended release, 6-month formulations of leuprolide acetate for the treatment of advanced prostate cancer: achieving testosterone levels below 20 ng/dl.
Crawford ED; Moul JW; Sartor O; Shore ND
Expert Opin Drug Metab Toxicol; 2015; 11(9):1465-74. PubMed ID: 26293510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
